Nanotechnology Revolutionizes Pharmaceutical Industry with Natural Products for Cancer Treatments

Researchers at the Federal University of Sergipe, Sao Cristovao, Brazil, have made significant findings on the integration of nanotechnology with natural products for developing cancer treatments and immunotherapies. Their study, published in the Beilstein Journal of Nanotechnology, reveals that nanotechnology provides significant advantages in controlling drug release, enhancing stability, and reducing adverse effects. The researchers identified 17 patents that utilize nanotechnology and natural products to develop cancer treatments and immunotherapies.

Key Takeaways:

• The combination of nanotechnology and natural products holds significant therapeutic potential for cancer treatments and immunotherapies.
• 17 patents were identified through free online databases of the European Patent Office (EPO) and the World Intellectual Property Organization (WIPO) that integrate nanotechnology with natural products.
• The most frequently identified natural products were ursolic acid, hyaluronic acid, and catechins, which have been shown to promote cell cycle arrest, reduce tumor size, and exhibit synergistic effects with other anticancer agents.
• The study discusses various types of nanotechnology, including nanoparticles, nanocarriers, and nanocapsules, as well as bioactive compounds primarily extracted from plants.
• The research aims to analyze publications that integrate nanotechnology with natural products to develop cancer treatments and immunotherapies.
• The study concluded that the combination of natural products with nanotechnology has significant therapeutic potential for cancer and immunotherapy.

Statistics:

• 17 patents were identified through free online databases of the EPO and WIPO.
• 3 natural products (ursolic acid, hyaluronic acid, and catechins) were identified as the most frequently used in the development of cancer treatments and immunotherapies.
• The study covers various types of nanotechnology, including nanoparticles, nanocarriers, and nanocapsules.

Sources:

• Beilstein Journal of Nanotechnology, 2025, 16(1): 1644-1667.
• Prospects of nanotechnology and natural products for cancer and immunotherapy.
• European Patent Office (EPO)
• World Intellectual Property Organization (WIPO)
• Beilstein-Institut (publisher of Beilstein Journal of Nanotechnology)